1. Achana FA, Sutton AJ, Kendrick D, Wynn P, Young B, Jones DR, et al. The effectiveness of different interventions to promote poison prevention behaviours in households with children : a network meta-analysis. PLoS One. 2015;10(4):1-18.
2. Achten J, Parsons NR, Bruce J, Petrou S, Tutton E, Willett K, et al. Protocol for a randomised controlled trial of standard wound management versus negative pressure wound therapy in the treatment of adult patients with an open fracture of the lower limb : UK wound management of open lower limb fractures (UK WOLFF). BMJ Open. 2015;5(9):1-10.
3. Batura N, Hill Z, Haghparast-Bidgoli H, Lingam R, Colbourn T, Kim S, et al. Highlighting the evidence gap: how cost-effective are interventions to improve early childhood nutrition and development? Health policy and planning. 2015;30(6):813-21.
4. Boyle EM, Johnson S, Manktelow B, Seaton SE, Draper ES, Smith LK, et al. Neonatal outcomes and delivery of care for infants born late preterm or moderately preterm : a prospective population-based study. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2015;100(6):F479-F85.
5. Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, et al. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. The British journal of dermatology. 2015;173(1):227-34.
6. Close H, Mason JM, Wilson DW, Hungin AP, Jones R, Rubin G. Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database. PLoS One. 2015;10(10):e0139745.
7. Colbourn T, Pulkki-Brannstrom AM, Nambiar B, Kim S, Bondo A, Banda L, et al. Cost-effectiveness and affordability of community mobilisation through women's groups and quality improvement in health facilities (MaiKhanda trial) in Malawi. Cost effectiveness and resource allocation : C/E. 2015;13(1):1.
8. Cornford CS, Close HJ, Bray R, Beere D, Mason JM. Contraceptive use and pregnancy outcomes among opioid drug-using women: a retrospective cohort study. PLoS One. 2015;10(3):e0116231.
9. Emmett CD, Close HJ, Yiannakou Y, Mason JM. Trans-anal irrigation therapy to treat adult chronic functional constipation: systematic review and meta-analysis. BMC gastroenterology. 2015;15:139.
10. Griffin DR, Hobson R, Wall PDH, Realpe A, Adams A, Parsons NR, et al. UK FASHIoN : Feasibility study for a randomised controlled trial comparing hip arthroscopy with best conservative care for patients with femoroacetabular impingement. Health Technology Assessment. 2015.
11. Griffiths FE, Atherton H, Barker JR, Cave JA, Dennick K, Dowdall P, et al. Improving health outcomes for young people with long term conditions: The role of digital communication in current and future patient–clinician communication for NHS providers of specialist clinical services for young people – LYNC study protocol. DIGITAL HEALTH. 2015;1:2055207615593698.
12. Harvey H, Good J, Mason J, Reissland N. A Q-methodology study of parental understandings of infant immunisation: Implications for health-care advice. Journal of health psychology. 2015;20(11):1451-62.
13. Harvey H, Reissland N, Mason J. Parental reminder, recall and educational interventions to improve early childhood immunisation uptake: A systematic review and meta-analysis. Vaccine. 2015;33(25):2862-80.
14. Hubbard S, Cooper N, Kendrick D, Young B, Wynn PM, He Z, et al. Network meta-analysis to evaluate the effectiveness of interventions to prevent falls in children under age 5 years. Injury Prevention. 2015;21(2):98-108.
15. Husereau D, Drummond M, Petrou S, Greenberg D, Mauskopf J, Augustovski F, et al. Reply to Roberts et al. : CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration. Springer; 2015. p. 535-6.
16. Jameson SS, Mason J, Baker P, Gregg PJ, Porter M, Deehan DJ, et al. Have cementless and resurfacing components improved the medium-term results of hip replacement for patients under 60 years of age? Acta orthopaedica. 2015;86(1):7-17.
17. Jameson SS, Mason J, Baker PN, Gregg PJ, Deehan DJ, Reed MR. Implant Optimisation for Primary Hip Replacement in Patients over 60 Years with Osteoarthritis: A Cohort Study of Clinical Outcomes and Implant Costs Using Data from England and Wales. PLoS One. 2015;10(11):e0140309.
18. Jameson SS, Mason JM, Baker PN, Gregg PJ, Deehan DJ, Reed MR. No functional benefit of larger femoral heads and alternative bearings at 6 months following primary hip replacement. Acta orthopaedica. 2015;86(1):32-40.
19. Johnson S, Evans TA, Draper ES, Field DJ, Manktelow BN, Marlow N, et al. Neurodevelopmental outcomes following late and moderate prematurity : a population-based cohort study. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2015;100(4):F301-F8.
20. Khan KA, Madan J, Petrou S, Lamb SE. Mapping between the Roland Morris Questionnaire and generic preference-based measures. Value in Health. 2015;17(6):686-95.
21. Khan KA, Petrou S, Dritsaki M, Johnson SJ, Manktelow B, Draper ES, et al. Economic costs associated with moderate and late preterm birth : a prospective population-based study. BJOG : An International Journal of Obstetrics & Gynaecology. 2015;122(11):1495-505.
22. Khunti K, Mani H, Achana FA, Cooper NS, Gray LJ, Davies MJ. Systematic review and meta-analysis of response rates and diagnostic yield of screening for type 2 diabetes and those at high risk of diabetes. PLoS One. 2015;10(9).
23. Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clinical Microbiology and Infection. 2015;21(6):568.e13-.e21.
24. Maheswaran H, Kupek E, Petrou S. Self-reported health and socio-economic inequalities in England, 1996–2009 : repeated national cross-sectional study. Social Science & Medicine. 2015;Volume 136-137:135-46.
25. Marlow N, Morris T, Brocklehurst P, Carr R, Cowan F, Patel N, et al. A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis : childhood outcomes at 5 years. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2015;100(4):F320-F6.
26. McKimm J, Sergio Da Silva AL, Edwards SL, Greenhill J and Taylor C (2015). ‘Women and Leadership in Medicine and Medical Education.’ In Tsouroufli M (Ed.) Gender, Careers and Inequalities in Medicine and Medical Education. London: Pan Macmillan. Published online: 25 Sep 2015; 69-98
27. Miranda CJ, Mason JM, Babu BI, Sheen AJ, Eddleston JM, Parker MJ, et al. Twenty-four hour infusion of human recombinant activated protein C (Xigris) early in severe acute pancreatitis: The XIG-AP 1 trial. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al]. 2015;15(6):635-41.
28. Nzenze SA, von Gottberg A, Shiri T, van Niekerk N, de Gouveia L, Violari A, et al. Temporal changes in pneumococcal colonization in HIV-infected and HIV-uninfected mother-child pairs following transitioning from 7-valent to 13-valent pneumococcal conjugate vaccine, Soweto, South Africa. The Journal of Infectious Diseases. 2015;212(7):1082-92.
29. Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ (Clinical research ed). 2015;350:h2958.
30. Petrou S, Morrell J, Knapp M. An overview of economics aspects of perinatal depression. In: Milgrom J, Gemmill AW, editors. Identifying perinatal depression and anxiety : evidence-based practice in screening, psychosocial assessment and management. Chichester, UK ; Malden, MA: Wiley-Blackwell Publishing Ltd.; 2015. p. 228-39.
31. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. The MAPS reporting statement for studies mapping onto generic preference-based outcome measures : explanation and elaboration. PharmacoEconomics. 2015;33(10):993-1011.
32. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. PharmacoEconomics. 2015;33(10):985-91.
33. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. Applied Health Economics and Health Policy. 2015;13(5):437-43.
34. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. Health and Quality of Life Outcomes. 2015;13.
35. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. Quality of Life Research. 2015;25(2):275-81.
36. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. Medical decision making. 2015;35(6):NP1-NP8.
37. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. Journal of Medical Economics. 2015;18(11):851-7.
38. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud RJ, et al. Preferred reporting items for studies mapping onto preference-based outcome measures : the MAPS statement. International Journal of Technology Assessment in Health Care. 2015;31(4):230-5.
39. Reissland N, Francis B, Kumarendran K, Mason J. Ultrasound observations of subtle movements: a pilot study comparing foetuses of smoking and nonsmoking mothers. Acta paediatrica (Oslo, Norway : 1992). 2015;104(6):596-603.
40. Sandhu H, Ellard DR, Achana FA, Antrobus JHL, Balasubramanian S, Brown S, et al. Facet-joint injections for people with persistent non-specific low back pain (FIS) : study protocol for a randomised controlled feasibility trial. Trials. 2015;16(1).
41. Smith LK, Draper ES, Evans TA, Field DJ, Johnson SJ, Manktelow BN, et al. Associations between late and moderately preterm birth and smoking, alcohol, drug use and diet : a population-based case–cohort study. Archives of Disease in Childhood. 2015;100(6):F486-F91.
42. Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, et al. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. The American journal of psychiatry. 2015;172(8):731-42.
43. Taylor CA, Green KE, Spruce A. Evaluation of the effect of socio-economic status on performance in a Multiple Mini Interview for admission to medical school. Medical teacher. 2015;37(1):59-63.
44. Torgerson C, Torgerson D and Taylor CA (2010). ‘Randomized Controlled Trials (RCTs) and Non-Randomized Designs.’ In Wholey JS, Hatry HP and Newcomer KE (Eds.) The Handbook of Practical Program Evaluation, Third Edition. San Francisco, CA. Jossey-Bass, 144-162.
    (2015). Fourth Edition, 158-176
45. Williams MA, Heine PJ, Williamson EM, Toye F, Dritsaki M, Petrou S, et al. Active treatment for idiopathic adolescent scoliosis (ACTIvATeS) : a feasibility study. Health Technology Assessment. 2015;19(55):1-242.
46. Wood VJ, Gesler W, Curtis SE, Spencer IH, Close HJ, Mason J, et al. 'Therapeutic landscapes' and the importance of nostalgia, solastalgia, salvage and abandonment for psychiatric hospital design. Health & place. 2015;33:83-9.